TARGETING THE GLUTAMINE TO PYRUVATE PATHWAY FOR TREATMENT OF ONCOGENIC KRAS-ASSOCIATED CANCER
- Application ID: EP13793114
- Status: █ APPLICATION WITHDRAWN
This patent has the IPC class C12 (BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING) Grund Intellectual Property Group is specialized in C12. Here you find a list of all patent agent firms which are specialized in this IPC class. For a similar patent, they might be a good choice.
- 24.05.2012 - Priority Date (US 201261651213P)
- 28.11.2013 - Publication A2 (WO2013177426)
- 08.04.2015 - Publication A2 (EP2855698)